We’re excited to announce that the Pharmaceutical Society of Nigeria (PSN), Lagos State Chapter, recently endorsed Amatem Softgel as a potent and patient compliant antimalarial of choice.
This recognition is yet another special backing following Amatem Softgel’s endorsement by the Association of Community Pharmacists of Nigeria at the 2019 ACPN National Conference which held in Kano State between June 1 – 4, 2019.
We received this recent seal of approval by the PSN Lagos at the Official Opening Ceremony of its 2019 Scientific Week. Speaking at the event, the General Manager of Elbe Pharma, Mr Shiva Kumar said: “This really means a lot to us at Elbe as it goes to show that our quest to find a superior, more acceptable antimalarial, is paying off. This journey started three years ago, and we are delighted at the positive feedback which Amatem Softgel is receiving from regulatory agencies, consumers, and the general public”.
About PSN Lagos
The Pharmaceutical Society of Nigeria (PSN) which is poised to reduce the menace of drug abuse and misuse within Nigeria, is a society of pharmacists all over the Federation.
Speaking at the endorsement event, the Chairman, Lagos State PSN, Pharm. (Mrs) Bolanle Adeniran shared that it was part of their obligations, as custodians of drugs, to monitor adverse drug reactions, and the degree of patients’ acceptance of a drug.
Both of which we have evaluated, and Amatem Softgel was not found wanting in any.”
The Publicity Secretary, Lagos PSN – Pharm. Ismail Sumonu also shared his thoughts about Amatem Softgel.
He said artemether-lumefantrine combination generally has a bitter taste and further explained that one of the unique selling points of Amatem Softgel is that it comes in a gelatin capsule, which masks the taste and odour of the combination.
“Also, in treating malaria, you realise that one of the challenges is vomiting, and for most patients, the odour of the drug triggers vomiting. But where you can mask taste and odour, you make the drug more acceptable by patients. So when we consider all of these, we realise it’s a major advantage over other brands of artemether-lumefantrine in the market,” He said.
About Amatem Softgel
Amatem Softgel successfully improves patients’ interaction with the artemether-lumefantrine combination. It is a research-based antimalarial Softgel formulation which replaced Amatem Forte- an artemether-lumefantrine tablet formulation.
Three years ago, we began our quest to find a superior and more acceptable antimalarial for our consumers and it led us to the introduction of what we currently have – Amatem Softgel.
According to Dr. Omoniyi Kayode Yemitan of the Department of Pharmacology, Therapeutics and Toxicology LASUTH, Amatem Softgel was found to be more available in the bloodstream than the tablet formulation of Artemether-Lumefantrine. The implication is that Amatem Softgel has a faster onset of action, and it’s more efficacious than tablet formulation.
Beyond its faster onset of action, Amatem Softgel succeeds in helping its users treat malaria better without an aftertaste, and it has no odour, making it easy to swallow. We considered all these characteristics during the experiment process with consumers in mind.
For us at Elbe Pharma and with Amatem Softgel, the goal remains to find antimalarial solutions that treat malaria better and faster without nasty experiences.
Amatem Softgel is readily available in many reputable pharmacies across the Federation.